HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hype

Trialists believe the results, at odds with the positive BrigHTN trial, stem from unexpected benefits in placebo-treated patients.

Related Keywords

New York , United States , American , Cincor Pharma , Deepak Bhatt , Manesh Patel , American College Of Cardiology World Congress , American Heart Association , Astrazeneca , Md Duke University , Icahn School , Mount Sinai , American College , World Congress , New Class , Duke University ,